Fennec Pharmaceuticals
FENC • NASDAQ • Stock Fundamentals
Fennec Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jeffrey S. Hackman, with a market cap of $343.5M.
Market Cap$343.5M
Employees29.0
CEOJeffrey S. Hackman
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 14, 2026 · 14 days agoQ1 2026
View reportNext EarningsAug 13, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Fennec Pharmaceuticals FAQ
Common questions about Fennec Pharmaceuticals
Fennec Pharmaceuticals (FENC) has a market capitalization of $343.5M and trades on NASDAQ.
Fennec Pharmaceuticals has approximately 29 employees.